GD1aCer (d18:1/12:0) is a sialic-acid-containing glycosphingolipid, which can be used as an effective standard in the research of the mechanism of cancer occurrence and development.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.